Latest News about NVO
Recent news which mentions NVO
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 01, 2025
From Benzinga
From Benzinga
US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
March 31, 2025
From Benzinga
While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
March 31, 2025
From Benzinga
Is Hims & Hers Stock Too Cheap to Pass Up?
March 29, 2025
From Motley Fool
Benzinga Bulls And Bears: Chevron, Microsoft, Nike — And Tariffs Have Automotive Sector Reeling
March 29, 2025
From Benzinga
Deal Dispatch: Bezos-Backed Crop Company Wilts, Tech Startup Nabs Napster For $207 Million
March 28, 2025
From Benzinga
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
March 28, 2025
From Benzinga
From Motley Fool
Why Novo Nordisk Stock Dipped on Thursday
March 27, 2025
From Motley Fool
1 Growth Stock Down 40% to Buy and Hold Forever
March 27, 2025
From Motley Fool
From Benzinga
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
March 26, 2025
From Benzinga
From Benzinga
From Motley Fool
Motley Fool 2025 March Market Cap Showdown Championship
March 24, 2025
From Motley Fool
From Benzinga
From Motley Fool
From Motley Fool
Is This Simple Index Fund a Millionaire Maker?
March 19, 2025
From Motley Fool
Is Novo Nordisk a No-Brainer Buy After It Dropped 40%?
March 19, 2025
From Motley Fool
UK Pharma Industry Trade Association Restores Wegovy/Ozempic Maker Novo Nordisk's Membership After 2 Years Of Suspension
March 17, 2025
From Benzinga
Why Hims & Hers Stock Popped on Monday
March 17, 2025
From Motley Fool
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2025
From Motley Fool
CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants
March 14, 2025
From Benzinga
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
March 14, 2025
From Benzinga
The Motley Fool's Market Volatility Toolkit
March 13, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.